{"id":180023,"name":"COREWELL HEALTH","slug":"corewell-health","state":"MI","country":"United States of America","description":"","totalSpending":3640000,"filings":34,"yearlySpending":[{"year":2018,"income":290000},{"year":2019,"income":180000},{"year":2020,"income":230000},{"year":2021,"income":220000},{"year":2022,"income":390000},{"year":2023,"income":880000},{"year":2024,"income":620000},{"year":2025,"income":830000}],"issues":[{"code":"HCR","display":"Health Issues"},{"code":"MMM","display":"Medicare/Medicaid"},{"code":"IMM","display":"Immigration"},{"code":"LBR","display":"Labor Issues/Antitrust/Workplace"},{"code":"PHA","display":"Pharmacy"},{"code":"TAR","display":"Tariff (miscellaneous tariff bills)"},{"code":"BUD","display":"Budget/Appropriations"}],"firms":["COREWELL HEALTH"],"lobbyists":["DAVID BILARDELLO","AMBER LANDIS","PHILIP YEITER","KRISTINA KO"],"govEntities":["HOUSE OF REPRESENTATIVES","SENATE","Centers For Medicare and Medicaid Services (CMS)","Health & Human Services, Dept of (HHS)","Food & Drug Administration (FDA)","Drug Enforcement Administration (DEA)","Executive Office of the President (EOP)"],"sampleDescriptions":["H.R.1625 Consolidated Appropriations Act, 2018\nH.R.2212 / S.974 Creating and Restoring Equal Access to Equivalent Samples (CREATES) Act of 2017: Discussions regarding proposed law to expedite generics","H.R.1625 Consolidated Appropriations Act, 2018\nH.R.4392 Discussions regarding bill to reverse CMS final rule reducing payments for the 340B program.\nH.R.908 Issues related to Medicare Advantage and th","H.R.4392 Discussions regarding bill to reverse CMS final rule reducing payments for the 340B program","H.R.908 Issues related to Medicare Advantage and the benchmark cap.","HR3325 & S.428:  ACE Kids Act\nHR908: Issues related to Medicare Advantage benefits and the benchmark cap.\nDiscussions regarding ACA Risk-Adjustment program"]}